Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant... – Molecular bilayer structure
Patent
1976-02-03
1978-05-09
Padgett, Benjamin R.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
Molecular bilayer structure
260518R, 424 9, 2604297, A61K 2700, A61K 4300
Patent
active
040887472
ABSTRACT:
A radiopharmaceutical for use on animals including human beings comprises a metal chelate in which the chelating agent is a phenolic amino carboxylic acid or an alkali salt thereof, and the metal is a pharmaceutically acceptable radio isotope such as technetium-99m. The chelating agent may be advantageously an ethylenediamine carboxylic acid or its salt having a phenolic group at each end of the molecule such as EDDHA and HBED or alternatively the phenolic amino carboxylic acid or its salt may have a single phenolate group such as HBG or HBS. The pharmaceutical has a balance of lipo-solubility and water-solubility to permit hepato-biliary imaging.
REFERENCES:
patent: RE23905 (1954-12-01), Bersworth
patent: 2624757 (1953-01-01), Bersworth
patent: 3509208 (1970-08-01), Alburn et al.
patent: 3749556 (1971-08-01), Barak et al.
patent: 3833590 (1974-09-01), Dazzi
Hunt Frederick C.
Wilson John G.
Australian Atomic Energy Commission
Nucker Christine M.
Padgett Benjamin R.
LandOfFree
Phenolic amino-carboxylic acid radiopharmaceuticals does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Phenolic amino-carboxylic acid radiopharmaceuticals, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Phenolic amino-carboxylic acid radiopharmaceuticals will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2357690